Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants
Inflammation resolution and matrix preservation Acute inflammation benefits: Initial inflammatory response (first days post-injury) clears debris, prevents infection, releases growth factors
Electrochemical methods for the analysis of clinically relevant biomolecules
Characterization of flavonoids from Dryopteris erythrosora and evaluation of their antioxidant, anticancer and acetylcholinesterase inhibition activities
What to keep in mind: Some people find the thigh slightly more sensitive than the abdomen, especially in the beginning
18 Diagnostic tools The Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale is a simple tool to further characterize a patients complaints and narrow the DDx